Celgene

Free public records show Celgene in 5 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by Celgene or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Celgene

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Home country
United States
Stock listing
NASDAQ: CELG
Legal name
CELGENE CORPORATION
Type
Medicines

Source: Wikidata, Company record Q842947. Retrieved 13 Nov 2026.

Source: GLEIF, Legal entity record, LEI 4SIHMF0MOSTTL8CD0X64. Retrieved 13 Nov 2026.

Trials over time

Studies Celgene leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Celgene or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Celgene: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Search all reports for Celgene All companies